Abby's

Volume 3 Issue 6

Issue link: https://cp.revolio.com/i/602310

Contents of this Issue

Navigation

Page 18 of 63

Vein Lite is a supplement that reduces amyloid beta deposits (Source: Chinese Journal of Ethnomedicine & Ethnopharmacy. 2009:9-10), which is one of the hallmarks of Alzheimer's disease and improves cardiovascular function. There is much evidence linking cardiovascular health to brain function, as we see in these cases. --- Featured Stories --- CASE 1: Heart Bypass Surgeries, Brain Atrophy, Short-Term Memory Loss T. Callaghan, MD from MS, has a 74-year-old male patient who has had 3 bypasses. He now has short- term memory loss, brain atrophy and balance issues when walking. He presents with a red lunula on the thumb, a sign of heart disease. CASE 2: Hypertension, Heavy Metal Toxicity, Severe Memory Loss F.F. is an 80-year-old female from Florida who has an ear crease and dark, protruding veins under the tongue. An ear crease signals heart disease. Dark protruding veins under the tongue signal heavy metal toxicity. She reveals that she does have hypertension, heavy metal toxicity and now has severe memory loss. Having these markers should already alert you to at least a risk for heart problems. Heavy metal toxicity, too, can lead to heart problems. Both of these affect the brain and cognitive function. As in the cases above, one has hypertension and heavy metal toxicity which affected her memory. The other one had heart problems (3 bypass surgeries) that also affected his brain and he developed Alzheimer's disease. Heart Disease Linked to Alzheimer's Disease Risk Back in 2010, Alzheimer's disease (AD) was already the 2nd most feared disease next to cancer in a survey on 1,007 American adults. In 2015, people worry about Alzheimer's disease almost as much as cancer (Source: Metlife Foundation). This worry is not unfounded. In the United States alone, there are more than 5 million people with Alzheimer's disease (AD) with one new case every 67 seconds. One in 10 adults over 65 years old are diagnosed with AD. Among those over 80 years old, 30% have AD symptoms: memory loss, lack of the sense of direction and time, language impediments, confusion, and so on. Once diagnosed, the progression of AD can cause organ failure and eventually death. With more and more people living beyond 90 years old, many fear developing Alzheimer's disease as it means you lose your dignity and are totally dependent on others. AD drugs that are available on the market target acetylcholine, which is low in AD and causes loss of memory and cognitive functions in AD patients. But the question is do you really want to wait until you develop AD before addressing it? Wouldn't it be better if you can reduce your risk for developing AD and perhaps avoid it altogether? Abby's Magazine - November/December 2015 | Page 19

Articles in this issue

Archives of this issue

view archives of Abby's - Volume 3 Issue 6